Skip to main content
. 2004 Mar;164(3):1063–1071. doi: 10.1016/S0002-9440(10)63193-8

Figure 5.

Figure 5

Verapamil treatment does not improve expression of the remaining sarcoglycan at the plasma membrane. The major sarcoglycan complex of cardiomyocytes is α-, β-, γ-, and δ-sarcoglycan. Antibodies specific to α-sarcoglycan, β-sarcoglycan, and δ-sarcoglycan were used on normal control and γ-sarcoglycan-null mice (gsg−/−) that were treated and untreated with verapamil. Scale bar, 10 μm.